Clinical Trial Detail

NCT ID NCT01961765
Title Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cabozantinib

Age Groups: adult

No variant requirements are available.